Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: An analysis from the Randomized Evaluation In Percutaneous Coronary Intervention Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial

Hitinder S. Gurm, Ian J. Sarembock, Dean J. Kereiakes, John J. Young, Robert A. Harrington, Neal Kleiman, Frederick Feit, Kathy Wolski, John A. Bittl, Robert Wilcox, Eric J. Topol, A. Michael Lincoff

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Fingerprint

Dive into the research topics of 'Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: An analysis from the Randomized Evaluation In Percutaneous Coronary Intervention Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences